Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sapna P Patel

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Melanoma Research|September 25, 2020
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanomaJane Mattei, Alexej Ballhausen, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2020
The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)Vivian Chua, Jane Mattei, Anna Han, et al.
Journal of Cutaneous Pathology|May 17, 2024
Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case reportSaul Turcios Escobar, Richard Yang, Kelly C Nelson, et al.
Cancers|December 23, 2022
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor GrowthChandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, et al.
Cancer Treatment Reviews|July 6, 2026
Neoadjuvant and adjuvant therapy in uveal melanoma: toward systemic control of a systemic diseaseDimitra Foteinou, Charalampos Theocharopoulos, Dimitrios Ν Varvoglis, et al.
Cancer|October 29, 2019
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case seriesKourtney Holbrook, Jose Lutzky, Michael A Davies, et al.
Pigment Cell & Melanoma Research|April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrumDouglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
Cancer Epidemiology|October 23, 2018
Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective studyKunhwa Kim, Tong Han Chung, Carol J Etzel, et al.
Journal of Immunotherapy and Precision Oncology|January 16, 2025
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B TrialMohamed A Gouda, Abdulrazzak Zarifa, Yali Yang, et al.
NPJ Precision Oncology|November 19, 2025
Conjunctival melanoma genomic analysis reveals intermediate tumor mutation burden and genomic overlap with cutaneous melanomaFlorentia Dimitriou, Xiaogang Wu, Priyadharsini Nagarajan, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Melanoma Research|September 25, 2020
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanomaJane Mattei, Alexej Ballhausen, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2020
The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)Vivian Chua, Jane Mattei, Anna Han, et al.
Journal of Cutaneous Pathology|May 17, 2024
Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case reportSaul Turcios Escobar, Richard Yang, Kelly C Nelson, et al.
Cancers|December 23, 2022
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor GrowthChandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, et al.
Cancer Treatment Reviews|July 6, 2026
Neoadjuvant and adjuvant therapy in uveal melanoma: toward systemic control of a systemic diseaseDimitra Foteinou, Charalampos Theocharopoulos, Dimitrios Ν Varvoglis, et al.
Cancer|October 29, 2019
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case seriesKourtney Holbrook, Jose Lutzky, Michael A Davies, et al.
Pigment Cell & Melanoma Research|April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrumDouglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
Cancer Epidemiology|October 23, 2018
Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective studyKunhwa Kim, Tong Han Chung, Carol J Etzel, et al.
Journal of Immunotherapy and Precision Oncology|January 16, 2025
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B TrialMohamed A Gouda, Abdulrazzak Zarifa, Yali Yang, et al.
NPJ Precision Oncology|November 19, 2025
Conjunctival melanoma genomic analysis reveals intermediate tumor mutation burden and genomic overlap with cutaneous melanomaFlorentia Dimitriou, Xiaogang Wu, Priyadharsini Nagarajan, et al.
Pageof 13